MEDINDIA
English
हिन्दी
Español
français
中文
Novartis and California-based biotech company Amgen will jointly develop neuroscience treatments for illnesses like Alzheimer's disease and migraine headaches.
Novartis Acquires Rights to GSK's Ofatumumab Drug For Multiple Sclerosis Treatment
The Swiss pharma will handle the worldwide development and commercialization of the drug - Ofatumumab - for use in multiple sclerosis, sources said.
The Swiss pharma will handle the worldwide development and commercialization of the drug - Ofatumumab - for use in multiple sclerosis, sources said.
Source-Medindia
Novartis' Oxytocin Nasal Spray can Help Men Reduce Calorie Intake
A new study has revealed that Novartis' oxytocin nasal spray, a synthetic nasal formulation of the love hormone, can help men eat fewer calories.
A new study has revealed that Novartis' oxytocin nasal spray, a synthetic nasal formulation of the love hormone, can help men eat fewer calories.
Young Blood to Cure Decline of Aging Brain
A research showed that injections of juvenile mouse blood boosts learning and memory in older rodents, findings that hold the long-sought cure for the decline of ageing brain.
A research showed that injections of juvenile mouse blood boosts learning and memory in older rodents, findings that hold the long-sought cure for the decline of ageing brain.
Brain Protein Could be Targeted to Slow Alzheimer�s, Study Reveals
A protein that is involved in limiting flexibility in the aging brain could be targeted by new treatments which can slow the progression of Alzheimer’s disease.
A protein that is involved in limiting flexibility in the aging brain could be targeted by new treatments which can slow the progression of Alzheimer’s disease.
Email
